While confident in the value of data, healthcare leaders remain frustrated by ongoing barriers to effective data usage, including siloed data (51%) and infrastructure limitations (23%). With cyberattacks increasingly targeting the healthcare sector, one in five (21%) cite concerns about data privacy and security as a top barrier to using data to its full potential. They also say greater data security and privacy systems and protocols are the top way to strengthen their trust in predictive analytics in both clinical (38%) and operational (35%) settings. Additionally, only 19% of healthcare leaders have all the internal expertise they need to fully use the data they have available, while 24% cite the availability of data specialists as a top factor in helping to better utilize data. Despite seeing the potential of data, as a result of these frustrations, nearly half of healthcare leaders (48%) view data as more of a burden than an asset today.

Leaders are fast-tracking social responsibility


The pandemic threw a spotlight on health inequality and healthcare leaders are responding. One-quarter (25%) see addressing health inequality as a priority today, compared to only 12% in 2021. Technology can play a part: two in three healthcare leaders (68%) agree that predictive analytics can have a positive impact on helping to reduce health disparities by providing fast and accurate insights on risk scores to help identify more vulnerable groups for proactive planning to help better manage community health issues like disease outbreaks, cancer incidences and more.

The 2022 report also sees healthcare leaders fast-tracking their sustainability plans. In 2021, just 4% of healthcare leaders worldwide were prioritizing environmental sustainability. This figure has jumped to 24% today; a more than six-fold increase year-over-year.

Since 2016, Philips has conducted original research to help determine the readiness of countries to address global health challenges and build efficient and effective health systems.


About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries.

Back to HCB News

Business Affairs Homepage